Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells

Cancer Research

Volumn 67, Issue 15, 2007, Pages 7088-7094

  Saletta, Federica ^a   Matullo, Giuseppe ^a,d   Manuguerra, Maurizio ^a   Arena, Sabrina ^a   Bardelli, Alberto ^a,b,e   Vineis, Paolo ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ISI FOUNDATION   (Italy)

^e CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; CARCINOGEN; METHYLNITRONITROSOGUANIDINE; TOBACCO SMOKE;

ARTICLE; BLADDER CANCER; CANCER RESEARCH; CELL CLONE; CELL STRAIN HCT116; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC STABILITY; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TOBACCO;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINOBIPHENYL COMPOUNDS; CARCINOGENS; CHROMOSOMAL INSTABILITY; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; HUMANS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION, FLUORESCENCE; METHYLNITRONITROSOGUANIDINE; MICROSATELLITE INSTABILITY; NUCLEAR PROTEINS; SMOKE; TOBACCO; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 34547646335     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4420     Document Type: Article

References (50)

1. Cairns J. The origin of human cancers. Nature 1981;289:353-7.
2. Norppa H, Bonassi S, Hansteen IL, et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 2006;600:37-45.
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
4. Duesberg P, Li R, Fabarius A, Hehlmann R. Aneuploidy and cancer: from correlation to causation. Contrib Microbiol 2006;13:16-44.
5. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol 1999;9:M57-60.
6. Vineis P, Berwick M. The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol 2006;35:1151-9.
7. Breivik J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005;15:51-60.
8. Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-6.
9. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86:712-6.
10. Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Semin Oncol 1996;23:536-45.
11. Vineis P, Talaska G, Malaveille C, et al. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996;65:314-6.
12. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 1994;102:7-10.
13. Airoldi L, Orsi F, Magagnotti C, et al. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 2002;23:861-6.
14. Parsons BL, Beland FA, Von Tungeln LS, Delongchamp RR, Fu PP, Heflich RH. Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumour development. Mol Carcinog 2005;42:193-201.
15. Feng Z, Hu W, Rom WN, Beland FA, Tang MS. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis 2002;23:1721-7.
16. Sugimura T, Terada M. Experimental chemical carcinogenesis in the stomach and colon. Jpn J Clin Oncol 1998;28:163-7.
17. Bardelli A, Cahill DP, Lederer G, et al. Carcinogen-specific induction of genetic instability. Proc Natl Acad Sci U S A 2001;98:5770-5.
18. Breivik J, Gaudernack G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 1999;9:245-54.
19. Duesberg P, Stindl R, Hehlmann R. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci U S A 2000;97:14295-300.
20. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor h type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
21. Zhou XP, Hoang JM, Li YJ, et al. Determination of the replication error phenotype in human tumours without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-7.
22. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
23. Koi M, Umar A, Chauhan DP, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumour cells with homozygous hMLH1 mutation. Cancer Res 1994;54:4308-12.
24. Masters JR. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 2000;1:233-6.
25. Williams SV, Adams J, Coulter J, Summersgill BM, Shipley J, Knowles MA. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro. Genes Chromosomes Cancer 2005;43:315-28.
26. de la Chapelle A. Testing tumours for microsatellite instability. Eur J Hum Genet 1999;7:407-8.
27. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
28. Rodriguez JW, Kirlin WG, Ferguson RJ, et al. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N- acetyltransferase expression in colon cytosol. Arch Toxicol 1993;67:445-52.
29. Faraglia B, Chen SY, Gammon MD, et al. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis 2003;24:719-25.
30. Airoldi L, Vineis P, Colombi A, et al. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev 2005;14:2118-24.
31. Feng Z, Hu W, Rom WN, et al. 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis 2002;23:1721-7.
32. Aebi S, Kurdi-Haidar B, Gordon R, et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 1996;56:3087-90.
33. Branch P, Aquilina G, Bignami M, Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993;362:652-4.
34. Deliveliotis C, Georgoulakis J, Skolarikos A, et al. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Urol Res 2005;33:39-43.
35. Fadl-Elmula I, Gorunova L, Mandahl N, et al. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromosomes Cancer 2000;29:256-65.
36. Fadl-Elmula I, Kytola S, Pan Y, et al. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Int J Cancer 2001;92:824-31.
37. Mitelman F, Johansson B, Mertens F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 2004;36:331-4.
38. Wagner U, Bubendorf L, Gasser TC, et al. Chromosome 8p deletions are associated with invasive tumour growth in urinary bladder cancer. Am J Pathol 1997;151:753-9.
39. Gibas Z, Gibas L. Cytogenetics of bladder cancer. Cancer Genet Cytogenet 1997;95:108-15.
40. Phillips JL, Richardson IC. Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice. BJU Int 2006;98:33-7.
41. Hurst CD, Fiegler H, Carr P, et al. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004;23:2250-63.
42. Sandberg AA. Cytogenetics and molecular genetics of bladder cancer: a personal view. Am J Med Genet 2002;115:173-82.
43. Hoglund M, Sall T, Heim S, et al. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res 2001;61:8241-6.
44. Sokolova IA, Halling KC, Jenkins RB, et al. T he development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2000;2:116-23.
45. Staub E, Grone J, Mennerich D, et al. A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 2006;5:37.
46. Knosel T, Schluns K, Dietel M, Petersen I. Chromosomal alterations in lung metastases of colorectal carcinomas: associations with tissue specific tumor dissemination. Clin Exp Metastasis 2005;22:533-8.
47. Knosel T, Petersen S, Schwabe H, et al. Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch 2002;440:187-94.
48. He QJ, Zeng WF, Sham JS, et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 2003;144:112-8.
49. Poeaim S, Rerkamnuaychoke B, Jesdapatarakul S, Campiranon A. Chromosome alterations in colorectal cancer in Thai patients. Cancer Genet Cytogenet 2005;160:152-9.
50. Halmes NC, Roberts SM, Tolson JK, Porier CJ. Reevaluating cancer risk estimates for short-term exposure scenarios. Toxicol Sci 2000;58:32-42.